Featured Research

from universities, journals, and other organizations

Body's own proteins may lead the way in global fight against tuberculosis

Date:
June 6, 2010
Source:
Federation of American Societies for Experimental Biology
Summary:
Scientists hope to counter the re-emerging threat of tuberculosis with help from proteins within our bodies. In new research, scientists show how the protein CCL5 plays a protective role in helping the body ward off TB in early stages of infection. CCL5 is a member of a large family of proteins responsible for immune cell migration toward infection sites.

Ohio scientists hope to counter the re-emerging threat of tuberculosis (TB) with help from proteins from our bodies. In a research report published in the June 2010 print issue of the Journal of Leukocyte Biology, scientists show how the protein CCL5 plays a protective role in helping the body ward off this contagious, airborne disease in the early stages of infection. CCL5 is a member of a large family of proteins responsible for immune cell migration toward infection sites.

The work on this molecule suggests that CCL5 and/or related proteins may lead to new therapies that help the immune system resist TB.

"We hope this study will spark interest in understanding the mechanisms which control cell migration to sites of infection, help define the protective immune response to Mycobacterium tuberculosis, and ultimately improve our capacity to predict and/or treat patients with TB," said Gillian Beamer, V.M.D, Dipl. ACVP, Ph.D., a researcher from the Center for Microbial Interface Biology at Ohio State University in Columbus, Ohio who was involved in the work.

Scientists discovered the role and potential benefits of CCL5 by studying mice lacking the gene to make the CCL5 protein and mice with the CCL5 gene. When both groups of mice were infected with Mycobacterium tuberculosis, those lacking CCL5 accumulated fewer protective cells and had more bacteria in the lungs over three to five weeks of infection when compared to the normal mice. After five weeks, differences between the groups were not apparent, leading researchers to conclude that CCL5 did not play a role in long-term infection, but rather in the onset and early protection against infection. Additionally, in humans, altered CCL5 expression may be a predisposing factor leading to TB disease progression.

"Tuberculosis may not be top of mind for most people in the developed world, but TB is a leading cause of global disease and drug resistant forms of TB are an ever increasing problem," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology. "Studies such as these this give us hope that as organisms evolve resistance to current therapies, we can develop promising new approaches to treat infectious disease."


Story Source:

The above story is based on materials provided by Federation of American Societies for Experimental Biology. Note: Materials may be edited for content and length.


Journal Reference:

  1. B. Vesosky, E. K. Rottinghaus, P. Stromberg, J. Turner, G. Beamer. CCL5 participates in early protection against Mycobacterium tuberculosis. Journal of Leukocyte Biology, 2010; DOI: 10.1189/jlb.1109742

Cite This Page:

Federation of American Societies for Experimental Biology. "Body's own proteins may lead the way in global fight against tuberculosis." ScienceDaily. ScienceDaily, 6 June 2010. <www.sciencedaily.com/releases/2010/06/100601101546.htm>.
Federation of American Societies for Experimental Biology. (2010, June 6). Body's own proteins may lead the way in global fight against tuberculosis. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2010/06/100601101546.htm
Federation of American Societies for Experimental Biology. "Body's own proteins may lead the way in global fight against tuberculosis." ScienceDaily. www.sciencedaily.com/releases/2010/06/100601101546.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins